SMAD2 and liver cancer: Interestingly, Holtzhausen et al. also noted greater co-expression of genes responsive to SMAD1/5/8 and SMAD2/3 in breast and liver cancer samples compared to normal tissues, suggesting cooperation between these two SMAD signaling pathways in cancer18.